Study C886R-US-16-040: A Field Study Investigating the Efficacy of Two Dose Levels of an Anti-IL-31 Monoclonal Antibody (IL-31 mAb) for Treatment of Allergic Dermatitis in Client-Owned Cats
|Effective start/end date||7/1/18 → 6/30/19|
- ALCHERABIO, LLC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.